By further adjusting model parameters to simulate a remnant kidney (using our previous approach for the rat [12, 43]), we can simulate the administration of SGLT2 inhibitors to a kidney with diabetic nephropathy. This evidence concerns the gene SLC5A2 and diabetic kidney disease.